Canavan disease: an Arab scenario
- PMID: 25668701
- DOI: 10.1016/j.gene.2015.02.009
Canavan disease: an Arab scenario
Abstract
The autosomal recessive Canavan disease (CD) is a neurological disorder that begins in infancy. CD is caused by mutations in the gene encoding the ASPA enzyme. It has been reported with high frequency in patients with Jewish ancestry, and with low frequency in non-Jewish patients. This review will shed light on some updates regarding CD prevalence and causative mutations across the Arab World. CD was reported in several Arab countries such as Saudi Arabia, Egypt, Jordan, Yemen, Kuwait, and Tunisia. The population with the highest risk is in Saudi Arabia due the prevalent consanguineous marriage culture. In several studies, four novel mutations were found among Arabian CD patients, including two missense mutations (p.C152R, p.C152W), a 3346bp deletion leading to the removal of exon 3 of the ASPA gene, and an insertion mutation (698insC). Other previously reported mutations, which led to damage in the ASPA enzyme activities found among CD Arab patients are c.530 T>C (p.I177T), c.79G>A (p.G27R), IVS4+1G>T, and a 92kb deletion, which is 7.16kb upstream from the ASPA start site. This review will help in developing customized molecular diagnostic approaches and promoting CD carrier screening in the Arab world in areas where consanguineous marriage is common particularly within Saudi Arabia.
Keywords: Arab countries; Canavan disease; Epidemiology; Genotype–phenotype correlation; Mutations.
Copyright © 2015 Elsevier B.V. All rights reserved.
Similar articles
-
Identification and characterization of novel mutations of the aspartoacylase gene in non-Jewish patients with Canavan disease.J Inherit Metab Dis. 2002 Nov;25(7):557-70. doi: 10.1023/a:1022091223498. J Inherit Metab Dis. 2002. PMID: 12638939
-
Fertility and family planning in the Arab region.IPPF Med Bull. 1986 Feb;20(1):1-3. IPPF Med Bull. 1986. PMID: 12267663
-
Canavan disease: mutations among Jewish and non-Jewish patients.Am J Hum Genet. 1994 Jul;55(1):34-41. Am J Hum Genet. 1994. PMID: 8023850 Free PMC article.
-
Canavan disease: diagnosis and molecular analysis.Genet Test. 1997;1(1):21-5. doi: 10.1089/gte.1997.1.21. Genet Test. 1997. PMID: 10464621 Review.
-
Canavan disease: studies on the knockout mouse.Adv Exp Med Biol. 2006;576:77-93; discussion 361-3. doi: 10.1007/0-387-30172-0_6. Adv Exp Med Biol. 2006. PMID: 16802706 Review.
Cited by
-
Current and Future Prospects for Gene Therapy for Rare Genetic Diseases Affecting the Brain and Spinal Cord.Front Mol Neurosci. 2021 Oct 6;14:695937. doi: 10.3389/fnmol.2021.695937. eCollection 2021. Front Mol Neurosci. 2021. PMID: 34690692 Free PMC article. Review.
-
Computational approach to unravel the impact of missense mutations of proteins (D2HGDH and IDH2) causing D-2-hydroxyglutaric aciduria 2.Metab Brain Dis. 2018 Oct;33(5):1699-1710. doi: 10.1007/s11011-018-0278-3. Epub 2018 Jul 9. Metab Brain Dis. 2018. PMID: 29987523
-
The pathogenesis of, and pharmacological treatment for, Canavan disease.Drug Discov Today. 2022 Sep;27(9):2467-2483. doi: 10.1016/j.drudis.2022.05.019. Epub 2022 May 27. Drug Discov Today. 2022. PMID: 35636725 Free PMC article. Review.
-
Comparative computational assessment of the pathogenicity of mutations in the Aspartoacylase enzyme.Metab Brain Dis. 2017 Dec;32(6):2105-2118. doi: 10.1007/s11011-017-0090-5. Epub 2017 Sep 6. Metab Brain Dis. 2017. PMID: 28879565
-
Structural modeling of p.V31F variant in the aspartoacylase gene.Metab Brain Dis. 2016 Jun;31(3):723-6. doi: 10.1007/s11011-016-9796-z. Epub 2016 Jan 21. Metab Brain Dis. 2016. PMID: 26797702
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical